Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Torrent Pharma

₹3358 25.8 | 0.8%

Market Cap ₹113650 Cr.

Stock P/E 68.6

P/B 15.1

Current Price ₹3358

Book Value ₹ 221.7

Face Value 5

52W High ₹3590

Dividend Yield 0.83%

52W Low ₹ 2025

Torrent Pharma Research see more...

Overview Inc. Year: 1972Industry: Pharmaceuticals & Drugs

Torrent Pharmaceuticals Ltd is an India-based pharmaceutical business enterprise. The Company is engaged in studies, improvement, manufacturing and advertising of generic pharmaceutical formulations. It operates in the gastrointestinal (GI), central nervous system (CNS),therapeutic segments of cardiovascular (CV), and vitamins minerals nutritionals (VMN). It additionally has presence in therapeutic areas, consisting of anti-epileptic, anti-diabetic, anti-most cancers, anti-zits, corticosteroids and cosmeceuticals. It has developed complex formulations for global markets based totally on oral solids, injections, inhalation technologies, long-appearing depot injections ophthalmic, nasal, semisolids for outside packages and multi-particulate extended-launch oral structures. The Company is growing numerous in-house new chemical entities (NCE) inside the regions of metabolic, cardiovascular, gastrointestinal, dermatological and breathing problems. It has a presence across more than forty countries.

Read More..

Torrent Pharma Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Torrent Pharma Quarterly Results

#(Fig in Cr.) Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 2347 2291 2491 2491 2591 2660 2732 2745 2859 2889
Other Income 30 16 -10 9 34 26 -33 31 24 -16
Total Income 2377 2307 2481 2500 2625 2686 2699 2776 2883 2873
Total Expenditure 1635 1612 1767 1764 1800 1835 1863 1862 1955 1950
Operating Profit 742 695 714 736 825 851 836 914 928 923
Interest 55 69 102 107 103 91 80 80 75 64
Depreciation 155 163 193 196 191 201 213 203 197 198
Exceptional Income / Expenses 0 0 0 0 0 0 88 0 0 0
Profit Before Tax 532 463 419 433 531 559 631 631 656 661
Provision for Tax 178 151 127 146 153 173 188 182 199 208
Profit After Tax 354 312 292 287 378 386 443 449 457 453
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 354 312 292 287 378 386 443 449 457 453
Adjusted Earnings Per Share 10.5 9.2 8.6 8.5 11.2 11.4 13.1 13.3 13.5 13.4

Torrent Pharma Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 4185 4653 6667 5816 5950 7673 7939 8005 8508 9620 10728 11225
Other Income 38 286 229 223 307 64 121 57 197 63 62 6
Total Income 4223 4939 6896 6039 6257 7736 8061 8061 8705 9683 10790 11231
Total Expenditure 3233 3633 3937 4438 4609 5696 5769 5524 6077 6796 7364 7630
Operating Profit 990 1306 2959 1601 1648 2040 2292 2537 2628 2887 3426 3601
Interest 59 175 184 206 308 504 451 353 255 333 354 299
Depreciation 87 191 238 307 409 618 654 658 662 707 808 811
Exceptional Income / Expenses 0 0 -194 0 0 -357 0 0 -485 0 88 88
Profit Before Tax 844 940 2343 1088 931 562 1187 1526 1226 1847 2352 2579
Provision for Tax 180 189 610 155 253 125 162 274 449 602 696 777
Profit After Tax 664 751 1733 934 678 436 1025 1252 777 1245 1656 1802
Adjustments -0 -0 -0 -0 -0 -0 0 0 0 0 0 0
Profit After Adjustments 664 751 1733 934 678 436 1025 1252 777 1245 1656 1802
Adjusted Earnings Per Share 19.6 22.2 51.2 27.6 20 12.9 30.3 37 23 36.8 48.9 53.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 12% 10% 7% 10%
Operating Profit CAGR 19% 11% 11% 13%
PAT CAGR 33% 10% 31% 10%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 62% 29% 29% 21%
ROE Average 25% 20% 21% 26%
ROCE Average 24% 20% 18% 22%

Torrent Pharma Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 1902 2491 3494 4350 4622 4724 4823 5837 5953 6198 6856
Minority's Interest 0 0 0 0 1 0 0 0 0 0 0
Borrowings 744 2185 1850 2241 4111 3913 3304 2941 2123 2496 1604
Other Non-Current Liabilities 182 320 145 62 31 -52 -5 -17 115 327 620
Total Current Liabilities 2175 2824 3285 2738 5202 5165 5454 4892 4415 5447 5425
Total Liabilities 5004 7820 8775 9392 13967 13751 13577 13653 12606 14468 14505
Fixed Assets 875 2833 2859 3688 7855 7748 7533 7065 6423 8121 8138
Other Non-Current Assets 724 936 1227 824 850 966 1062 1065 889 1018 756
Total Current Assets 3404 4051 4688 4879 5262 5038 4979 5522 5165 5314 5611
Total Assets 5004 7820 8775 9392 13967 13751 13577 13653 12606 14468 14505

Torrent Pharma Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 687 955 612 1050 1068 702 589 662 573 398 509
Cash Flow from Operating Activities 599 810 2742 1009 894 1798 1393 2005 1803 2368 3266
Cash Flow from Investing Activities -356 -2162 -838 -787 -4707 -241 199 -449 -197 -2415 -168
Cash Flow from Financing Activities 86 1212 -1435 -193 3417 -1314 -1549 -1651 -1781 77 -2780
Net Cash Inflow / Outflow 330 -140 469 29 -395 242 42 -95 -175 30 319
Closing Cash & Cash Equivalent 955 865 1050 1068 702 940 662 573 398 509 835

Torrent Pharma Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 19.61 22.19 51.21 27.58 20.03 12.89 30.27 36.99 22.96 36.79 48.94
CEPS(Rs) 22.18 27.82 58.23 36.65 32.11 31.14 49.61 56.42 42.52 57.67 72.82
DPS(Rs) 10 11.25 17.5 14 14 17 32 35 48 22 28
Book NAV/Share(Rs) 56.21 73.58 103.23 128.52 136.56 139.58 142.5 172.45 175.87 183.13 202.57
Core EBITDA Margin(%) 22.7 21.89 40.82 23.52 11.91 13.61 14.51 16.67 15.98 17.3 20.13
EBIT Margin(%) 21.53 23.92 37.8 22.09 11.01 7.33 10.95 12.63 9.74 13.36 16.2
Pre Tax Margin(%) 20.13 20.16 35.05 18.58 8.27 3.87 7.94 10.26 8.06 11.32 14.08
PAT Margin (%) 15.84 16.11 25.92 15.94 6.02 3 6.85 8.41 5.11 7.63 9.92
Cash Profit Margin (%) 17.91 20.2 29.47 21.18 9.65 7.26 11.23 12.84 9.46 11.96 14.75
ROA(%) 15.16 11.71 20.89 10.28 5.81 3.15 7.5 9.2 5.92 9.2 11.43
ROE(%) 39.94 34.19 57.92 23.8 15.12 9.34 21.47 23.49 13.18 20.5 25.38
ROCE(%) 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35 20.32 24.28
Receivable days 77.81 105.19 82.76 74.66 35.74 33.78 37.65 38.92 37.86 39.99 41.38
Inventory Days 84.02 81.17 66.19 90.9 57.16 49.01 49.84 59.24 61.71 52.47 49.26
Payable days 411.42 464.01 520.94 449.01 451.45 370.58 381.76 383.19 306.08 243.5 279.66
PER(x) 13.35 26.16 13.08 28.09 31.14 75.73 32.56 34.35 60.89 41.79 53.15
Price/Book(x) 4.66 7.89 6.49 6.03 4.57 6.99 6.92 7.37 7.95 8.4 12.84
Dividend Yield(%) 1.91 0.97 2.61 0.9 1.12 0.87 1.62 1.38 1.72 1.43 1.08
EV/Net Sales(x) 2.2 4.69 3.66 4.79 4.49 4.99 4.85 5.9 5.99 5.9 8.5
EV/Core EBITDA(x) 9.32 16.71 8.24 17.39 16.21 18.75 16.82 18.62 19.38 19.66 26.61
Net Sales Growth(%) 30.32 11.2 43.27 -12.77 2.31 28.96 3.47 0.82 6.29 13.07 11.51
EBIT Growth(%) 46.67 23.53 126.68 -48.82 -4.19 -14.04 53.68 14.78 -21.19 47.24 24.08
PAT Growth(%) 52.65 13.11 130.8 -46.14 -27.36 -35.66 134.86 22.17 -37.92 60.22 33.02
EPS Growth(%) 53.41 13.11 130.81 -46.14 -27.36 -35.66 134.88 22.17 -37.92 60.23 33.02
Debt/Equity(x) 0.59 1.1 0.67 0.58 1.4 1.28 1.21 0.83 0.68 0.85 0.57
Current Ratio(x) 1.57 1.43 1.43 1.78 1.01 0.98 0.91 1.13 1.17 0.98 1.03
Quick Ratio(x) 1.11 1.06 1.02 1.22 0.64 0.6 0.52 0.59 0.62 0.57 0.62
Interest Cover(x) 15.4 6.37 13.74 6.29 4.02 2.11 3.63 5.32 5.81 6.54 7.65
Total Debt/Mcap(x) 0.13 0.14 0.1 0.1 0.31 0.18 0.18 0.11 0.08 0.1 0.04

Torrent Pharma Shareholding Pattern

# Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
FII 10.8 11.37 12.09 12.04 12.84 13.15 14.09 14.14 14.22 14.46
DII 10.01 9.51 8.87 9 8.31 8 7.21 7.26 7.27 7.08
Public 7.95 7.88 7.8 7.71 7.6 7.6 7.45 7.36 7.26 7.21
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 30% CAGR over last 5 years
  • Company has reduced debt.

Cons

  • Debtor days have increased from 243.5 to 279.66days.
  • Stock is trading at 15.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Torrent Pharma News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....